NCT05127109

Brief Summary

This is a research study to determine if a particular method of providing nutrition improves the clinical outcomes of patients in the intensive care unit (ICU) who have undergone abdominal surgery and would require nutrition delivered via the bloodstream (called total parenteral nutrition or TPN). The nutrition method we are testing is a structured nutrition delivery plan that involves tube feeding, oral nutrition supplements, and the use of a device (called an indirect calorimeter or IC) to measure calorie needs. This study will also use two devices to measure fat and muscle mass to examine changes during hospitalization. Subjects will be followed throughout hospitalization where nutrition status and fat and muscle mass will be closely monitored. Study activities will begin within 72 hours of a patient's abdominal surgery. TPN (total parenteral nutrition, a method of feeding that bypasses the usual process of eating and digestion) will be started, a non-invasive method of assessing calorie needs (indirect calorimetry (IC)) will be started, a urine sample will be collected to help assist in protein needs, and fat/muscle mass will be measured using bioelectrical impedance analysis (BIA), and an ultrasound. This is a minimal risk study and all products/devices used are non-invasive and FDA-approved. Indirect calorimetry and urine sample collection will be conducted every 3 days during the stay in the Intensive Care Unit - ICU, then every 5 days until hospital discharge. BIA and muscle ultrasound will be conducted every 7 days during ICU stay, then every 14 days until hospital discharge.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for phase_4

Timeline
10mo left

Started Apr 2022

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Apr 2022Feb 2027

First Submitted

Initial submission to the registry

November 9, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 19, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

April 25, 2022

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2027

Expected
Last Updated

April 23, 2026

Status Verified

January 1, 2026

Enrollment Period

3.8 years

First QC Date

November 9, 2021

Last Update Submit

April 22, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of nosocomial infection complications as measured by medical record review

    From TPN initiation, daily until hospital discharge (up to 8 months)

  • ICU length of stay in days measured by medical record review

    From TPN initiation, daily until hospital discharge (up to 8 months)

Secondary Outcomes (11)

  • Incidence of protein-calorie malnutrition measured using AND/ASPEN-defined malnutrition criteria

    Measured daily from hospital admission to hospital discharge (up to 8 months)

  • Number of days patient is on ventilator measured by medical record review

    Measured daily from hospital admission up to hospital discharge (up to 8 months)

  • Number of patients discharged home measured by medical record review/patient report

    Recorded at hospital discharge (up to 8 months)]

  • Number of patients discharged to rehabilitation center measured by medical record review/patient report

    Recorded at hospital discharge (up to 8 months)]

  • Number of patients discharged to nursing home measured by medical record review/patient report

    Recorded at hospital discharge (up to 8 months)]

  • +6 more secondary outcomes

Study Arms (2)

Nutrition Ecosystem pathway

EXPERIMENTAL

1. parenteral nutrition initiated within 72 hours of operative intervention 2. metabolic cart assessments to determine resting energy expenditure (REE) and guide registered dietitians (RDs) 3. expedited delivery of oral nutrition supplements and 4. a team-based approach on proper documentation of nutrition delivery and intake.

Combination Product: Nutrition Ecosystem pathway

Comparator

OTHER

300 historical matched control subjects not having received TPN in the first 7 hospital days will be enrolled from Duke Electronic Health Record between January 2018 and June 2020.

Other: Comparator

Interventions

retrospective cohort of 300 historical matched control subjects

Comparator
Nutrition Ecosystem pathwayCOMBINATION_PRODUCT

1. parenteral nutrition initiated within 72 hours of operative intervention * Provided as clinically appropriate: Ensure Enlive, Ensure High-Protein, Nepro with Carb-Steady/ProSource Gelatein Plus, and/or ProSource Gelatein Plus 2. metabolic cart assessments to determine resting energy expenditure (REE) and guide registered dietitians (RDs) * Q-NRG Metabolic Cart (Indirect Calorimeter) and Quark RMR Metabolic Cart (Indirect Calorimeter) * BWA 2.0 Advanced Bioelectric Impedance Spectroscopy (BIS) * Philips Lumify L12-4 broadband linear array transducer ultrasound 3. expedited delivery of oral nutrition supplements and 4. a team-based approach on proper documentation of nutrition delivery and intake

Nutrition Ecosystem pathway

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>= 18 years
  • ICU admission with major abdominal trauma, intra-abdominal sepsis, ischemic bowel/vascular emergencies, or penetrating trauma
  • Not expected to receive oral or enteral nutrition for \> 72 hours
  • Primary team approval of PN
  • \. \< 72 hours post-operative intervention

You may not qualify if:

  • Expected death or withdrawal of life-sustaining treatment within the first 72 hours of ICU admission
  • Patients admitted with
  • Diabetic ketoacidosis or non-ketotic hyperosmolar coma
  • MELD \> 20 or acute fulminant hepatic failure
  • Patients allergic to any component of parenteral nutrition or lipid solution
  • Pregnant or breastfeeding patients
  • Incarcerated or prisoner prior to admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

MeSH Terms

Conditions

Abdominal InjuriesIntraabdominal InfectionsSepsis

Condition Hierarchy (Ancestors)

Wounds and InjuriesInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Paul Wischmeyer

    Duke University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Utilization of structured nutrition delivery pathway on 300 adult abdominal trauma and surgery patients admitted to a Duke University Medical Center (DUMC) intensive care unit (ICU) from surgical intervention to hospital discharge.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2021

First Posted

November 19, 2021

Study Start

April 25, 2022

Primary Completion

February 20, 2026

Study Completion (Estimated)

February 20, 2027

Last Updated

April 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations